# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Timestamp:** 2026-01-30T22:28:44.244820
**Response ID:** resp_04d3b221c0b522b600697d211ae380819380945771091d2802
**Tokens:** 36042 in / 2824 out
**Response SHA256:** 842392fa442e33c9

---

I checked the draft strictly for **fatal** problems in (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency across the reported numbers/tables/figures.

### 1) Data–Design Alignment (critical)
- **Treatment timing vs. data coverage:** Your ACS outcome panel is **2015–2019 and 2021–2022** (no 2020). The latest treatment cohort you use is **2021**, so **max(treatment year) ≤ max(data year)** holds.
- **Post-treatment observations:** Each contributing cohort (2016–2021) has post-treatment observations in the outcome data. The **2020 cohort (NM)** has post-treatment outcomes in **2021–2022** even though 2020 outcomes are missing; that is still logically feasible for ATT estimation.
- **Treatment definition consistency:** The cohort list in **Table 7** matches the treatment definition used throughout (first year MW gap ≥ $1.00, with your stated “predominant rate for the calendar year” rule).

**No fatal data/design misalignment detected.**

### 2) Regression Sanity (critical)
I scanned all reported regression/ATT tables for broken outputs:
- No impossible R² values (all reported R² are between 0 and 1 where shown).
- No negative/NA/Inf/NaN SEs or coefficients.
- No coefficients with implausible magnitudes for a percentage-point outcome.
- No SEs that are orders of magnitude off (largest is Table 3, e = −4: SE = 3.441, which is big but not mechanically impossible given thin cohort support at that relative time).

**No fatal regression-output problems detected.**

### 3) Completeness (critical)
- All main regression tables report **effect estimates and standard errors** and include **N** (e.g., Table 2, Table 4).
- No placeholders (TBD/XXX/NA) in tables/figures.
- Tables and figures referenced in the text appear to be present in the provided draft excerpt (Tables 1–10; Figures 1–6).

**No fatal completeness issues detected.**

### 4) Internal Consistency (critical)
- Key headline numbers match across locations (e.g., CS-DiD ATT = −0.540, SE = 0.446 appears consistently in Abstract / Table 2 / Table 3).
- Sample sizes match stated panel construction (51 × 7 = 357; dropping 2021 gives 306; pre-pandemic 2015–2019 gives 255).
- Treatment cohort counts sum correctly to 31 treated + 20 never-treated (Table 7).
- The outcome component means are arithmetically consistent (Table 1: independent = alone + spouse + partner).

**No fatal internal inconsistencies detected.**

ADVISOR VERDICT: PASS